• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在基层医疗中使用国际标准化比值即时检测进行高质量的口服抗凝治疗。

Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.

作者信息

Løkkegaard Thomas, Pedersen Tina Heidi, Lind Bent, Siersma Volkert, Waldorff Frans Boch

机构信息

The Research Unit for General Practice in Copenhagen, P.O. Box 2099, 1014 Copenhagen, Denmark.

出版信息

Dan Med J. 2015 Feb;62(2).

PMID:25634508
Abstract

INTRODUCTION

Oral anticoagulation treatment (OACT) with warfarin is common in general practice. Increasingly, international normalised ratio (INR) point of care testing (POCT) is being used to manage patients. The aim of this study was to describe and analyse the quality of OACT with warfarin in general practice in the Capital Region of Denmark using INR POCT.

METHODS

A total of 20 general practices, ten single-handed and ten group practices using INR POCT, were randomly selected to participate in the study. Practice organisation and patient characteristics were recorded. INR measurements were collected retrospectively for a period of six months. For each patient, time in therapeutic range (TTR) was calculated and correlated with practice and patient characteristics using multilevel linear regression models.

RESULTS

We identified 447 patients in warfarin treatment in the 20 practices using POCT (median = 19 patients; range: 6-55). The mean TTR for all patients was 69.3% (standard deviation (SD) = 24%), and for all practices the mean TTR was 67.3% (SD = 6.7%). The TTR in single-handed practices was lower than in group practices, 64.6% (SD = 8.0%) and 70.0% (SD = 3.6%), respectively; but the difference was not significant (4.2 percentage points (pp); 95% confidence interval (CI): -0.8-9.2). Short sampling intervals, e.g. 10-20 days (-11 pp; 95% CI: -16-6)) and lack of diagnostic coding (-11.8 pp; 95% CI: -19.9-3.7) were correlated with a low TTR.

CONCLUSION

In our study most of the general practices using INR POCT in the management of patients in warfarin treatment provided good quality of care. Sampling interval and diagnostic coding were significantly correlated with treatment quality.

摘要

引言

在全科医疗中,使用华法林进行口服抗凝治疗(OACT)很常见。国际标准化比值(INR)即时检验(POCT)越来越多地用于管理患者。本研究的目的是描述和分析丹麦首都地区全科医疗中使用INR POCT进行华法林OACT的质量。

方法

随机选择20家使用INR POCT的全科诊所,其中10家单人诊所和10家联合诊所参与研究。记录诊所组织情况和患者特征。回顾性收集六个月期间的INR测量值。对于每位患者,计算治疗范围内时间(TTR),并使用多水平线性回归模型将其与诊所及患者特征相关联。

结果

我们在使用POCT的20家诊所中确定了447例接受华法林治疗的患者(中位数=19例;范围:6 - 55例)。所有患者的平均TTR为69.3%(标准差(SD)=24%),所有诊所的平均TTR为67.3%(SD = 6.7%)。单人诊所的TTR低于联合诊所,分别为64.6%(SD = 8.0%)和70.0%(SD = 3.6%);但差异不显著(4.2个百分点(pp);95%置信区间(CI):-0.8 - 9.2)。较短的采样间隔,例如10 - 20天(-11 pp;95% CI:-16 - 6))和缺乏诊断编码(-11.8 pp;95% CI:-19.9 -

相似文献

1
Good quality of oral anticoagulation treatment in general practice using international normalised ratio point of care testing.在基层医疗中使用国际标准化比值即时检测进行高质量的口服抗凝治疗。
Dan Med J. 2015 Feb;62(2).
2
Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.基于国际标准化比值自我检测、在线远程监测与管理以及低剂量维生素K并考虑基因组因素的华法林管理评估:一项试点研究。
Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22.
3
Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.为忙碌的临床医生定义治疗范围内的时间:剂量变化频率是识别华法林抗凝效果欠佳患者的良好替代指标。
Thromb Res. 2014 Sep;134(3):584-6. doi: 10.1016/j.thromres.2014.06.024. Epub 2014 Jul 6.
4
Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.新华法林患者口服抗凝控制的决定因素:来自临床实践研究数据库的数据分析。
Thromb Res. 2015 Aug;136(2):250-60. doi: 10.1016/j.thromres.2015.06.007. Epub 2015 Jun 9.
5
Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).儿童口服抗凝治疗的床旁监测。使用国际参考凝血活酶制剂(rTF/95)对CoaguChek XS系统与静脉血国际标准化比值(INR)及静脉血INR进行比较。
Thromb Haemost. 2009 Jul;102(1):159-65. doi: 10.1160/TH09-01-0056.
6
Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.随机比较一种简单的华法林剂量算法与计算机化的抗凝管理系统,以控制华法林维持治疗。
Thromb Haemost. 2012 Dec;108(6):1228-35. doi: 10.1160/TH12-06-0433. Epub 2012 Sep 26.
7
Improving anticoagulation therapy using point-of-care testing and a standardized protocol.使用即时检验和标准化方案改善抗凝治疗。
Ann Fam Med. 2008 Jan-Feb;6 Suppl 1(Suppl 1):S28-32. doi: 10.1370/afm.739.
8
STABLE results: warfarin home monitoring achieves excellent INR control.STABLE研究结果:华法林居家监测可实现出色的国际标准化比值(INR)控制。
Am J Manag Care. 2014 Mar;20(3):202-9.
9
[Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study].[西班牙马德里市初级保健中口服抗凝治疗的质量控制:CHRONOS-TAO研究]
Med Clin (Barc). 2015 Sep 7;145(5):192-7. doi: 10.1016/j.medcli.2014.09.023. Epub 2014 Nov 26.
10
Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment).德国全科医生诊所中维生素 K 拮抗剂口服抗凝治疗质量的差异 - 集群随机 PICANT 试验(优化抗血栓治疗的初级保健管理)的结果。
BMC Health Serv Res. 2019 Aug 1;19(1):539. doi: 10.1186/s12913-019-4372-y.

引用本文的文献

1
Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands.荷兰全科医疗中房颤患者口服抗凝药物处方模式:一项观察性研究
BJGP Open. 2023 Mar 21;7(1). doi: 10.3399/BJGPO.2022.0179. Print 2023 Mar.
2
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study.非维生素 K 拮抗剂口服抗凝剂和华法林在心房颤动中的有效性和安全性:一项斯堪的纳维亚基于人群的队列研究。
Eur Heart J Qual Care Clin Outcomes. 2022 Aug 17;8(5):577-587. doi: 10.1093/ehjqcco/qcab048.
3
Sense of Coherence and Quality of Life in Patients Treated with Antivitamin K Oral Anticoagulants: A Cross-Sectional Study.
抗维生素 K 口服抗凝剂治疗患者的整体感和生活质量:一项横断面研究。
Int J Environ Res Public Health. 2021 Feb 9;18(4):1668. doi: 10.3390/ijerph18041668.
4
[Prevalence of oral anticoagulation and quality of its management in primary healthcare: A study by the Health Sentinel Network of the Region of Valencia (Spain)].[西班牙巴伦西亚地区健康哨兵网络的一项研究:初级医疗保健中口服抗凝治疗的患病率及其管理质量]
Aten Primaria. 2017 Nov;49(9):534-548. doi: 10.1016/j.aprim.2016.11.015. Epub 2017 Apr 10.
5
Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults--Ineffectiveness of Oral Anticoagulation Treatment with VKA.心房颤动注册研究(AFABE)结果:成人未诊断与已注册心房颤动之间的差距——维生素K拮抗剂口服抗凝治疗的无效性
Biomed Res Int. 2015;2015:134756. doi: 10.1155/2015/134756. Epub 2015 Jul 1.